Pherecydes Pharma SA :Reg-Erytech Announces That The Commercial Court Has Rejected Akkadian'S Request To Postpone The Vote On The Merger With Pherecydes Pharma.Erytech Pharma Sa - Erytech Shareholders Will Be Able To Legitimately Vote On Merger On June 23, 2023.Erytech Pharma Sa - Expert Has Been Appointed To Examine Merger Parity And Must Submit His Report To Parties Within 4 Months.Erytech Pharma Sa - Akkadian Partners Has To Cover Costs Of This Expert Appraisal.Erytech Pharma Sa - Akkadian Partners Has Also Been Ordered To Indemnify Erytech For Costs Incurred By Company In This Procedure.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments